Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
QureBio Ltd. to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI Meetings 2022-12-21 10:30
PeproMene Bio, Inc. Announced Complete Response of The First Patient Treated in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope 2022-12-21 09:00
Ascletis' NASH Drug ASC41(THRβ) Phase II Enrollment is Progressing as Planned 2022-12-21 08:00
WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index 2022-12-21 08:00
Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio 2022-12-21 00:06
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi 2022-12-20 23:16
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia 2022-12-20 20:00
The Top 8 Best Places to Work in Philippines for 2022 revealed 2022-12-20 19:56
PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT 2022-12-20 19:21
Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries 2022-12-20 17:00
Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination 2022-12-19 23:07
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory Board 2022-12-19 22:00
SeekIn Receives CE-IVD Mark Approval for PanCanSeek® Cancer Mutation Detection Kit 2022-12-19 21:00
Ascletis Announces Notice of Issuance of the U.S. Patent for Oral Viral Polymerase Inhibitor ASC10 and Its Derivatives 2022-12-19 18:10
TG ImmunoPharma (TGI) announces FDA clearance of IND application for TGI-2, a novel anti-PVRIG therapeutic antibody 2022-12-17 21:30
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology 2022-12-16 19:56
Novavax Announces Pricing of $65 Million Public Offering of Common Stock 2022-12-16 14:49
Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes 2022-12-16 14:18
WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Commerce Department's Unverified List 2022-12-16 08:44
Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes 2022-12-15 23:43
1 135 136 137 138 139 452